Mr. Jonathan Tegge - 23 Dec 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Interim CFO
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Jonathan Tegge
Issuer symbol
INM
Transactions as of
23 Dec 2023
Net transactions value
$0
Form type
4
Filing time
26 Dec 2023, 13:08:36 UTC
Previous filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +30,000 +2143% $0.000000 31,400 23 Dec 2023 Common shares 30,000 $0.3700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).